Neurobehavioral Effects from Developmental Methamphetamine Exposure

Sarah A Jablonski1, Michael T Williams2, Charles V Vorhees3

  • 1Division of Neurology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., R-1447, Cincinnati, OH, 45229-3039, USA. sarah.jablonski@cchmc.org.

Insights

Prenatal methamphetamine exposure can harm brain development, leading to cognitive deficits. The timing of exposure is critical, with third-trimester equivalent exposure causing lasting spatial navigation issues in animal models.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Toxicology

Background:

  • Intrauterine methamphetamine exposure is linked to cognitive deficits in children.
  • Developmental outcomes in animal models depend on the timing of drug exposure.

Purpose of the Study:

  • To review the impact of developmental methamphetamine exposure on neural circuitry, neurotransmission, and behavior in animal models.
  • To analyze how the timing of drug exposure influences neurodevelopmental outcomes.

Main Methods:

  • Review of existing literature on animal models of developmental methamphetamine exposure.
  • Categorization of findings by type of effect and timing of drug exposure (prenatal, neonatal).

Main Results:

  • Third-trimester equivalent methamphetamine exposure causes persistent spatial navigation deficits in rodents.
  • Exposure during earlier human equivalent periods (first and second trimesters) does not produce similar deficits.
  • Findings highlight the role of specific brain structures (frontal cortex, striatum) and neurotransmitters (dopamine, serotonin).

Conclusions:

  • The timing of prenatal methamphetamine exposure significantly influences neurodevelopmental and behavioral outcomes.
  • Developmental neurotoxicity is mediated by alterations in neural circuitry and neurotransmitter systems.
  • Understanding these patterns is crucial for addressing the long-term consequences of prenatal drug exposure.